Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology granted inducement stock options to purchase 133,750 shares to five new employees on May 1, 2026. The options carry an exercise price of $8.77 per share, equal to the closing price on the grant date, and vest over four years.
Key figures
- Exercise price
- 8.77
- Options granted
- 133750
- Employees affected
- 5
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.